ErbB signaling pathway；HIF-1 signaling pathway；Cell cycle；p53 signaling pathway；PI3K-Akt signaling pathway；Hepatitis C；Hepatitis B；Bladder cancer；Chronic myeloid leukemia；Melanoma；HTLV-I infection；Glioma；Epstein-Barr virus infection；Pathways in cancer；Transcriptional misregulation in cancer；Prostate cancer；Viral carcinogenesis；Proteoglycans in cancer

circMTO1 suppresses HCC progression by acting as the sponge of oncogenic miR-9 to promote p21 expression, suggesting that circMTO1 is a potential target in HCC treatment.

circMTO1 suppresses HCC progression by acting as the sponge of oncogenic miR-9 to promote p21 expression, suggesting that circMTO1 is a potential target in HCC treatment.